Search

FDA Proposal to Withdraw or Repeal Statutory Evaluations

The Food and Drug Administration, along with other HHS agencies, has proposed to withdraw or repeal certain statutory evaluations. This action is part of an effort to secure updated and necessary evaluations. The proposal is open for public comment.

Approval of Respiratory Protective Devices

The Public Health Service, through the Department of Health and Human Services, has issued a final rule regarding the approval of respiratory protective devices. This rule is published in the Federal Register and pertains to specific regulations within 42 CFR 84.

FDA Delays Effective Date for Statutory Evaluations

The Food and Drug Administration (FDA) has issued a correction to delay the effective date for certain statutory evaluations. This administrative delay affects rules published under the Department of Health and Human Services and its various agencies.

High Intensity Drug Trafficking Areas Designation

The Office of National Drug Control Policy has designated five new areas as High Intensity Drug Trafficking Areas (HIDTA). This designation aims to enhance federal, state, and local law enforcement efforts to combat drug trafficking in these specific regions.

Privacy Act of 1974; System of Records Notice

The Office of National Drug Control Policy (ONDCP) has published a notice establishing a new system of records, "Correspondence Management systems (CMS) for the Office of National Drug Control Policy (ONDCP), ONDCP/001." This system will track correspondence received, sent, or referred to the ONDCP.

Appointment of Senior Executive Service Performance Review Board members

The Office of National Drug Control Policy has published a notice announcing the appointment of members to its Senior Executive Service Performance Review Board. This notice serves to inform the public of these appointments.

Appointment of Senior Executive Service Performance Review Board Members

The Office of National Drug Control Policy has published a notice announcing the appointment of members to its Senior Executive Service Performance Review Board. This action is part of the agency's internal administrative processes for evaluating executive performance.

ONDCP Appointment of Senior Executive Service Performance Review Board Members

The Office of National Drug Control Policy (ONDCP) has published a notice announcing the appointment of four individuals to its Senior Executive Service Performance Review Board. The notice identifies Ms. Michele Marx as Chair, along with Ms. Debbie Seguin, Ms. Shannon Kelly, and Mr. Kemp Chester as members.

Office of the Secretary Cancellation of Meeting

The National Institutes of Health, through the Office of the Secretary, has issued a notice cancelling a previously scheduled meeting. The notice was published in the Federal Register on March 16, 2026.

Center for Scientific Review Notice of Closed Meetings

The National Institutes of Health (NIH) Center for Scientific Review has issued a notice regarding upcoming closed meetings. These meetings are scheduled for April 13-14, 2026, and are part of the review process for grant applications.